John Goh

Dopaminergic Therapeutics for Treating Parkinson’s Disease Were Associated with a Shift in the Gut Microbiota to Resemble Healthy Individuals

Parkinson’s Disease (PD) is a neurodegenerative disorder associated with dopaminergic neuron loss, leading to dopamine dysregulation. Dopaminergic therapeutics are often administered to restore dopamine levels and have been associated with changes to the gut microbiota. Through a...